Simone Brunnschweiler

Papers

Total Citations

H-Index

About

Simone Brunnschweiler is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in robotic-assisted laparoscopic radical prostatectomy (RARP), particularly for patients on antiplatelet therapy. Her most cited study, "Continuous Low-Dose Aspirin Therapy in Robotic-Assisted Laparoscopic Radical Prostatectomy Does Not Increase Risk of Surgical Hemorrhage" (2013, 17 citations), challenged conventional practice by demonstrating that maintaining low-dose aspirin during RARP does not elevate bleeding risk. This finding has significant clinical implications, as it helps reduce thrombotic complications—such as stent thrombosis, myocardial infarction, and stroke—that can arise from withdrawing antiplatelet agents before surgery. By providing evidence for safer perioperative management, Brunnschweiler’s work supports a shift toward individualized, risk-adapted protocols. Her contributions are particularly valuable for patients with cardiovascular comorbidities, offering a pathway to minimize both surgical and thrombotic risks. With a focused yet impactful body of research, Brunnschweiler continues to advance the safety and precision of robotic urologic surgery, making her a notable voice in the field.